glp-1 lawsuit news today 2025 Lawsuits claiming Ozempic, other GLP-1s led to blindness become second mass litigation over the drugs Novo Nordisk A/S (NVO) Securities

Regardless of adherence, adults with obesity receiving semaglutide tablets 25mg achieved 13.6% weight loss, compared with 2.4% with placebo after 64 weeks, in addition to lifestyle modifications

A law firm may also help calculate losses tied to medical expenses, lost earnings, physical pain and suffering, emotional distress, and reduced quality of life resulting from severe complications associated with GLP-1 medications

H.PagottoU.et al

fda.gov/news-events/pr

The drug was also found to slow down the progression of kidney disease in such patients (Marso, Daniels, Brown-Frandsen)

Proton pump inhibitors (PPIs) such as omeprazole, esomeprazole, or pantoprazole effectively reduce gastric acid production and are generally safe for concurrent use with GLP-1 medications